Dr. Afshin James Khodabakhsh, MD

Dr. Khodabakhsh practices at Specialty Surgical Center of Beverly Hills (Wilshire Blvd) in Beverly Hills, California.

Dr. Khodabakhsh's NPI, 1306957329, was assigned on August 31, 2006. Dr. Khodabakhsh graduated from SUNY Downstate Health Sciences University in 1996. Dr. Khodabakhsh's California license number on file is A85260.

Dr. Khodabakhsh's primary practice is Specialty Surgical Center of Beverly Hills (Wilshire Blvd), at 9001 Wilshire Blvd, Suite 100, Beverly Hills, CA 90211. The practice phone is (310) 275-2339.

Dr. Khodabakhsh's primary practice is Specialty Surgical Center of Beverly Hills (Wilshire Blvd) in Beverly Hills, California. Dmand AI also links Dr. Khodabakhsh to 2 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Khodabakhsh practices, 3 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Khodabakhsh's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Khodabakhsh is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Khodabakhsh's licenses on file in 3 states: California, New York and New Jersey.

Dmand AI lists age-related macular degeneration, cataract, cataract surgery with lens implant, cold sores or genital herpes, conjunctivitis, dry eye, eye infection or inflammation and eyelid inflammation among the conditions Dr. Khodabakhsh treats.

CMS data shows 4,082 Medicare services from Dr. Khodabakhsh across 16 procedure codes in 2024, for 1,403 Medicare patients. Medicare paid $427,599 for them.

CMS counts 1,403 Medicare patients who saw Dr. Khodabakhsh in 2024. The largest group is 75 to 84, with 641 patients. 75% of them have high cholesterol, and 67% have high blood pressure. 9% are also on Medicaid. Their average risk score is 1.02, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Khodabakhsh's median patient age at 73, with 57% women.

In 2024, Dr. Khodabakhsh wrote 1,879 Medicare Part D claims for 485 patients. 55% of them were for generic drugs. CMS names the drug for 1,748 of them, across 18 drugs with 11 or more claims each, at $221,527 in total drug cost. In 2023, CMS named 1,766 claims across 21 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Khodabakhsh for performance year 2024, reported individually. Dr. Khodabakhsh accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 530 procedures of cataract surgery by Dr. Khodabakhsh, more than 96% of the clinicians it reports for that procedure.

Dmand AI links 5 papers to Dr. Khodabakhsh in 2018. The most frequent topics are Phacoemulsification and Visual Acuity. Dr. Khodabakhsh's most frequent co-author is John David Hofbauer, MD.

CMS Open Payments shows 752 general payments to Dr. Khodabakhsh from 42 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 29% of the total. Bausch & Lomb Americas Inc. paid the most, $67,717. It also lists 1 research payment totaling $36,000 in 2016.

Dmand AI lists 3 awards for Dr. Khodabakhsh, most recently Regional Top Doctor in 2014.

Dr. Khodabakhsh graduated from SUNY Downstate Health Sciences University in 1996. Dr. Khodabakhsh is a member of AAO.

Dr. Khodabakhsh is in network with 7 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.